Resources tagged with:
China

Five actions pharmaceutical and biotechnology companies can take before the BIOSECURE Act passes.

 

A joint white paper with Health-ISAC and CyberCX

 

Biotechnology is a high-value target for strategically, economically, and commercially motivated threat actors. The Health-ISAC Threat Operations Center and CyberCX Intelligence assess three key angles to understanding biotechnology as a target.

 

With the BIOSECURE Act likely to pass and disrupt pharmaceutical supply chains and research and development, pharmaceutical and biotechnology companies should immediately begin preparing. Read the paper to gain some recommendations for actions companies can take today.

 

Access the white paper here:

Click Here

 

White paper research insights powered by RANE.

This week, Hacking Healthcare™  begins with a look at concerns over China’s use of exit bans. We examine what they are, how they are being used by the Chinese government, and some considerations Health-ISAC members may wish to think about. Next, we take a look at an upcoming law in the U.S. state of Florida that is set to prohibit the offshoring of some healthcare data.